- Home
- ZLAB vs HTLF Comparison
ZLAB vs HTLF Comparison
Compare ZLAB & HTLF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZLAB
- HTLF
- Stock Information
- Founded
- ZLAB 2013
- HTLF 1981
- Country
- ZLAB China
- HTLF United States
- Employees
- ZLAB N/A
- HTLF N/A
- Industry
- ZLAB Biotechnology: Pharmaceutical Preparations
- HTLF Major Banks
- Sector
- ZLAB Health Care
- HTLF Finance
- Exchange
- ZLAB Nasdaq
- HTLF Nasdaq
- Market Cap
- ZLAB 3.0B
- HTLF 2.5B
- IPO Year
- ZLAB 2017
- HTLF N/A
- Fundamental
- Price
- ZLAB $26.91
- HTLF $65.55
- Analyst Decision
- ZLAB Strong Buy
- HTLF Buy
- Analyst Count
- ZLAB 4
- HTLF 5
- Target Price
- ZLAB $52.50
- HTLF $45.60
- AVG Volume (30 Days)
- ZLAB 960.6K
- HTLF 175.8K
- Earning Date
- ZLAB 11-12-2024
- HTLF 01-27-2025
- Dividend Yield
- ZLAB N/A
- HTLF 1.79%
- EPS Growth
- ZLAB N/A
- HTLF N/A
- EPS
- ZLAB N/A
- HTLF 1.80
- Revenue
- ZLAB $355,748,000.00
- HTLF $571,472,000.00
- Revenue This Year
- ZLAB $48.50
- HTLF N/A
- Revenue Next Year
- ZLAB $47.37
- HTLF N/A
- P/E Ratio
- ZLAB N/A
- HTLF $36.21
- Revenue Growth
- ZLAB 35.01
- HTLF N/A
- 52 Week Low
- ZLAB $13.48
- HTLF $32.03
- 52 Week High
- ZLAB $36.60
- HTLF $70.27
- Technical
- Relative Strength Index (RSI)
- ZLAB 45.71
- HTLF 48.20
- Support Level
- ZLAB $25.85
- HTLF $64.64
- Resistance Level
- ZLAB $29.87
- HTLF $66.97
- Average True Range (ATR)
- ZLAB 1.05
- HTLF 1.57
- MACD
- ZLAB -0.18
- HTLF -0.56
- Stochastic Oscillator
- ZLAB 21.98
- HTLF 16.99
About ZLAB Zai Lab Limited
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-2306 for treatments across multiple solid tumor types including ovarian and certain types of breast and lung cancers; ZL-2401 which is an antibiotic in a new class of tetracycline derivatives; and ZL-2301 is an oral, small molecule which targets HCC.
About HTLF Heartland Financial USA Inc.
Heartland Financial USA Inc is a multi-bank holding company that offers a wide range of commercial, small business, and consumer banking services to businesses, including public sector and non-profit entities and individuals. It also provides traditional and non-traditional service channels including online banking, mobile and remote banking, and telephone banking. The company's business lines are Commercial Banking, Agricultural Loans, Small Business Banking, Residential Real Estate Mortgage Lending, Consumer Banking, and Wealth Management and Retirement Plan Services.